This report contains market size and forecasts of Angiotensin Receptor Blockers (ARBs) in global, including the following market information:
Global Angiotensin Receptor Blockers (ARBs) Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Angiotensin Receptor Blockers (ARBs) Market Sales, 2016-2021, 2022-2027, (K MT)
Global top five Angiotensin Receptor Blockers (ARBs) companies in 2020 (%)
The global Angiotensin Receptor Blockers (ARBs) market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Angiotensin Receptor Blockers (ARBs) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Angiotensin Receptor Blockers (ARBs) Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K MT)
Global Angiotensin Receptor Blockers (ARBs) Market Segment Percentages, By Type, 2020 (%)
Valsartan
Telmisartan
Losartan
Irbesartan
Azilsartan
Olmesartan

Global Angiotensin Receptor Blockers (ARBs) Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K MT)
Global Angiotensin Receptor Blockers (ARBs) Market Segment Percentages, By Application, 2020 (%)
Hypertension
Cardiovascular Diseases
Kidney Diseases
Other

Global Angiotensin Receptor Blockers (ARBs) Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K MT)
Global Angiotensin Receptor Blockers (ARBs) Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Angiotensin Receptor Blockers (ARBs) revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Angiotensin Receptor Blockers (ARBs) revenues share in global market, 2020 (%)
Key companies Angiotensin Receptor Blockers (ARBs) sales in global market, 2016-2021 (Estimated), (K MT)
Key companies Angiotensin Receptor Blockers (ARBs) sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Novartis
Merck
Astra Zeneca
Jhonson and Johnson
Eli Lilly
Sanofi
Bristol-Myers Squibb
Bayer
GSK
Teva Pharmaceutical